Friday, November 27, 2020 2:26:38 AM
DPLS - ENZC - Comparison Analysis
I'll Alert you of stocks to Buy,
before the Run happens !
_________________________________________________________________
DPLS Security Details
Share Structure
Market Value1...........$1,226,629 a/o Nov 25, 2020
Authorized Shares..20,000,000,000 a/o Nov 24, 2020
Outstanding Shares..4,088,762,156 a/o Nov 24, 2020
Restricted...............31,894,998 a/o Nov 24, 2020
Unrestricted..........4,056,867,158 a/o Nov 24, 2020
Held at DTC...............Not Available
Float.....................Not Available
Par Value 0.01
https://www.otcmarkets.com/stock/DPLS/security
https://www.otcmarkets.com/stock/DPLS/news
https://www.otcmarkets.com/stock/DPLS/disclosure
Authorized Shares,
has No Bearing on the price.
The Shares Authorized,
is not used in any fundamental of financial calculation,
to determine company value.
_________________________________________________________________
ENZC Security Details
Share Structure
Market Value1...........$91,036,113 a/o Nov 25, 2020
Authorized Shares...3,000,000,000 a/o Nov 09, 2020
Outstanding Shares..2,758,670,097 a/o Nov 09, 2020
Restricted..............887,839,585 a/o Nov 09, 2020
Unrestricted..........1,870,830,512 a/o Nov 09, 2020
Held at DTC...........1,660,574,659 a/o Nov 09, 2020
Float...............1,670,830,512 Sep 30, 2020
Par Value 0.001
https://www.otcmarkets.com/stock/ENZC/security
https://www.otcmarkets.com/stock/ENZC/news
https://www.otcmarkets.com/stock/ENZC/disclosure
_________________________________________________________________
_________________________________________________________________
Live! Chart
_________________________________________________________________
ENZC - Price jumps to 0.0095
News Catalyst
September 16, 2020
https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1693758
https://www.ldmicro.com/profile/enzc/news/7730961669761459
Enzolytics, Inc.
today announced
the execution of a non-binding
letter of intent (the "LOI")
to merge with
BioClonetics Immunotherapeutics, Inc.
("BCLS" or "BioClonetics")
a biotech company located in Dallas Texas.
_________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume
from Aug 28 thru Sep 18
https://www.otcmarkets.com/stock/ENZC/overview
_________________________________________________________________
Embedded and Live! Charts
_________________________________________________________________
_________________________________________________________________
ENZC - Price jumps to 0.0095
News Catalyst
September 16, 2020
https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1693758
https://www.ldmicro.com/profile/enzc/news/7730961669761459
Enzolytics, Inc.
today announced
the execution of a non-binding
letter of intent (the "LOI")
to merge with
BioClonetics Immunotherapeutics, Inc.
("BCLS" or "BioClonetics")
a biotech company located in Dallas Texas.
_________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume
from Aug 28 thru Sep 18
https://www.otcmarkets.com/stock/ENZC/overview
_________________________________________________________________
Embedded and Live! Charts
_________________________________________________________________
ENZC - Price jumps to 0.0095
News Catalyst
September 16, 2020
https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1693758
https://www.ldmicro.com/profile/enzc/news/7730961669761459
Enzolytics, Inc.
today announced
the execution of a non-binding
letter of intent (the "LOI")
to merge with
BioClonetics Immunotherapeutics, Inc.
("BCLS" or "BioClonetics")
a biotech company located in Dallas Texas.
_________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume
from Aug 28 thru Sep 18
https://www.otcmarkets.com/stock/ENZC/overview
Embedded and Live! Charts
_________________________________________________________________
ENZC - Price jumps to 0.0095
News Catalyst
September 16, 2020
https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1693758
https://www.ldmicro.com/profile/enzc/news/7730961669761459
Enzolytics, Inc.
today announced
the execution of a non-binding
letter of intent (the "LOI")
to merge with
BioClonetics Immunotherapeutics, Inc.
("BCLS" or "BioClonetics")
a biotech company located in Dallas Texas.
_________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume
from Aug 28 thru Sep 18
https://www.otcmarkets.com/stock/ENZC/overview
______________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
I'll Alert you of stocks to Buy,
before the Run happens !
_________________________________________________________________
DPLS Security Details
Share Structure
Market Value1...........$1,226,629 a/o Nov 25, 2020
Authorized Shares..20,000,000,000 a/o Nov 24, 2020
Outstanding Shares..4,088,762,156 a/o Nov 24, 2020
Restricted...............31,894,998 a/o Nov 24, 2020
Unrestricted..........4,056,867,158 a/o Nov 24, 2020
Held at DTC...............Not Available
Float.....................Not Available
Par Value 0.01
https://www.otcmarkets.com/stock/DPLS/security
https://www.otcmarkets.com/stock/DPLS/news
https://www.otcmarkets.com/stock/DPLS/disclosure
Authorized Shares,
has No Bearing on the price.
The Shares Authorized,
is not used in any fundamental of financial calculation,
to determine company value.
_________________________________________________________________
ENZC Security Details
Share Structure
Market Value1...........$91,036,113 a/o Nov 25, 2020
Authorized Shares...3,000,000,000 a/o Nov 09, 2020
Outstanding Shares..2,758,670,097 a/o Nov 09, 2020
Restricted..............887,839,585 a/o Nov 09, 2020
Unrestricted..........1,870,830,512 a/o Nov 09, 2020
Held at DTC...........1,660,574,659 a/o Nov 09, 2020
Float...............1,670,830,512 Sep 30, 2020
Par Value 0.001
https://www.otcmarkets.com/stock/ENZC/security
https://www.otcmarkets.com/stock/ENZC/news
https://www.otcmarkets.com/stock/ENZC/disclosure
_________________________________________________________________
_________________________________________________________________
Live! Chart
_________________________________________________________________
ENZC - Price jumps to 0.0095
News Catalyst
September 16, 2020
https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1693758
https://www.ldmicro.com/profile/enzc/news/7730961669761459
Enzolytics, Inc.
today announced
the execution of a non-binding
letter of intent (the "LOI")
to merge with
BioClonetics Immunotherapeutics, Inc.
("BCLS" or "BioClonetics")
a biotech company located in Dallas Texas.
_________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume
from Aug 28 thru Sep 18
https://www.otcmarkets.com/stock/ENZC/overview
_________________________________________________________________
Embedded and Live! Charts
_________________________________________________________________
_________________________________________________________________
ENZC - Price jumps to 0.0095
News Catalyst
September 16, 2020
https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1693758
https://www.ldmicro.com/profile/enzc/news/7730961669761459
Enzolytics, Inc.
today announced
the execution of a non-binding
letter of intent (the "LOI")
to merge with
BioClonetics Immunotherapeutics, Inc.
("BCLS" or "BioClonetics")
a biotech company located in Dallas Texas.
_________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume
from Aug 28 thru Sep 18
https://www.otcmarkets.com/stock/ENZC/overview
_________________________________________________________________
Embedded and Live! Charts
_________________________________________________________________
ENZC - Price jumps to 0.0095
News Catalyst
September 16, 2020
https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1693758
https://www.ldmicro.com/profile/enzc/news/7730961669761459
Enzolytics, Inc.
today announced
the execution of a non-binding
letter of intent (the "LOI")
to merge with
BioClonetics Immunotherapeutics, Inc.
("BCLS" or "BioClonetics")
a biotech company located in Dallas Texas.
_________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume
from Aug 28 thru Sep 18
https://www.otcmarkets.com/stock/ENZC/overview
Embedded and Live! Charts
_________________________________________________________________
ENZC - Price jumps to 0.0095
News Catalyst
September 16, 2020
https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1693758
https://www.ldmicro.com/profile/enzc/news/7730961669761459
Enzolytics, Inc.
today announced
the execution of a non-binding
letter of intent (the "LOI")
to merge with
BioClonetics Immunotherapeutics, Inc.
("BCLS" or "BioClonetics")
a biotech company located in Dallas Texas.
_________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume
from Aug 28 thru Sep 18
https://www.otcmarkets.com/stock/ENZC/overview
______________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.